Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
The live-attenuated yellow fever 17D (YF17D) vaccine is one of the most efficacious human vaccines and also employed as a vector for novel vaccines. However, in the lack of appropriate immunocompetent small animal models, mechanistic insight in YF17D-induced protective immunity remains limited. To b...
Main Authors: | Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe, Niraj Mishra, Thomas Vercruysse, Dieudonné Buh Kum, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.2008772 |
Similar Items
-
Limited evolution of the yellow fever virus 17d in a mouse infection model
by: Dieudonné Buh Kum, et al.
Published: (2019-01-01) -
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice
by: Dieudonné Buh Kum, et al.
Published: (2020-01-01) -
A High-Throughput Yellow Fever Neutralization Assay
by: Madina Rasulova, et al.
Published: (2022-06-01) -
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
by: Robbert Boudewijns, et al.
Published: (2021-08-01) -
A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine
by: Kexin Yan, et al.
Published: (2020-07-01)